Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Innovate Biopharma Acquires Assets Related to RG-1068 from Repligen 11
Venture Financing 12
Innovate Biopharma Raises USD1.5 Million in Venture Financing 12
Innovate Biopharma Raises USD1.4 Million in Venture Financing 13
Innovate Biopharma Raises USD2.7 Million in Venture Financing 14
Partnerships 15
Innovate Biopharma Enters into Agreement with Amarex Clinical Research 15
IB Pharma Enters into Agreement with University of Virginia School of Medicine 16
Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 17
Merger 18
Monster Digital Completes Reverse Merger Transaction with Innovate Biopharma 18
Licensing Agreements 20
Innovate Biopharm Enters into Licensing Agreement with Alba Therapeutics 20
Equity Offering 21
IB Pharma Plans to Raise up to USD175 Million in Public Offering of Shares 21
IB Pharma Plans to Raise Funds through Public Offering of Shares 22
IB Pharma Raises USD23.5 Million in Private Placement of Securities 23
Debt Offering 24
IB Pharma Raises USD4.8 Million in Private Placement of Debt Securities 24
IB Pharmaceuticals Inc – Key Competitors 25
IB Pharmaceuticals Inc – Key Employees 26
IB Pharmaceuticals Inc – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Aug 15, 2018: Innovate Biopharmaceuticals announces second quarter 2018 financial results 28
May 16, 2018: Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights 29
Corporate Communications 30
Jun 13, 2018: Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D. 30
Mar 13, 2018: Innovate Biopharmaceuticals Names June Almenoff As Chief Operating Officer And Chief Medical Officer 31
Product Approvals 32
Sep 06, 2017: Innovate Biopharmas Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation 32
Jul 12, 2017: Innovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis Indication 33
Clinical Trials 34
Feb 21, 2017: Innovate Biopharmaceuticals To Highlight Its Late-Stage Product Pipeline Targeting Celiac Disease And Ulcerative Colitis At The Cowen Healthcare Conference On March 6, 2017 34
Jan 04, 2017: Innovate Biopharmaceuticals Provides Update on INN-108 Phase 2 Trial 35
Jan 04, 2017: Innovate Biopharmaceuticals Provides Update on larazotide acetate (INN-202) 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IB Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Innovate Biopharma Acquires Assets Related to RG-1068 from Repligen 11
Innovate Biopharma Raises USD1.5 Million in Venture Financing 12
Innovate Biopharma Raises USD1.4 Million in Venture Financing 13
Innovate Biopharma Raises USD2.7 Million in Venture Financing 14
Innovate Biopharma Enters into Agreement with Amarex Clinical Research 15
IB Pharma Enters into Agreement with University of Virginia School of Medicine 16
Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 17
Monster Digital Completes Reverse Merger Transaction with Innovate Biopharma 18
Innovate Biopharm Enters into Licensing Agreement with Alba Therapeutics 20
IB Pharma Plans to Raise up to USD175 Million in Public Offering of Shares 21
IB Pharma Plans to Raise Funds through Public Offering of Shares 22
IB Pharma Raises USD23.5 Million in Private Placement of Securities 23
IB Pharma Raises USD4.8 Million in Private Placement of Debt Securities 24
IB Pharmaceuticals Inc, Key Competitors 25
IB Pharmaceuticals Inc, Key Employees 26
List of Figures
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IB Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9